Form 4 for BJDX Bluejay Diagnostics, Inc.
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-01 · accession 0001213900-23-010880 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-13 | 2023-02-01 | BJDX | Fisher Kenneth R | CFO | A - Grant | $0.44 | +112.5K | 152.5K | +281% | +$49.5K | |
| 2023-02-13 | 2023-02-01 | BJDX | Fisher Kenneth R | CFO | F - Tax | $0.44 | -39.3K | 113.2K | -26% | -$17.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | A | A | 112,500 | $0.44 | 152,500 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-01 | F | D | 39,316 | $0.44 | 113,184 | D | — | — |